Inventor · disambiguated record
Stuart Emanuel
Also filed as: EMANUEL STUART · EMANUEL STUART L
30 granted patents·10 pending applications·398 citations·filing 1997–2023
97Inventor score
Files withBRISTOL MYERS SQUIBB CO9JANSSEN BIOTECH INC9JANSSEN PHARMACEUTICA NV8ORTHO MCNEIL PHARM INC4CONNOLLY PETER J3
Top patents by PatentIndex Score
40 records- 0196US9920108B2Targeted therapeutics based on engineered proteins that bind EGFRBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 20, 2018·19 cites·14 claims
- 0296US9771411B2Method of treating cancer by administering EGFR and EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 26, 2017·22 cites·20 claims
- 0396US9017655B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Apr 28, 2015·36 cites·10 claims
- 0496US8524244B2Targeted therapeutics based on engineered proteins that bind EGFRCAMPHAUSEN RAY·Filed 2009·Granted Sep 3, 2013·44 cites·24 claims
- 0596US8343501B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 1, 2013·45 cites·19 claims
- 0696US7541367B23-benzoimidazolyl-pyrazolopyridines useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 2, 2009·104 cites·38 claims
- 0795US9234028B2Targeted therapeutics based on engineered proteins that bind EGFRBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 12, 2016·30 cites·19 claims
- 0891US10183987B2Polynucleotides encoding bispecific EGFR/IGF-IR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 22, 2019·7 cites·13 claims
- 0990US10954286B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 23, 2021·2 cites·20 claims
- 1089US10781247B2Targeted therapeutics based on engineered proteins that bind EGFRBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 22, 2020·3 cites·17 claims
- 1189US7855205B2Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 21, 2010·9 cites·88 claims
- 1286US7317031B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2005·Granted Jan 8, 2008·5 cites·11 claims
- 1384US6710048B2Pyrazine derivatives as modulators of tyrosine kinasesORTHO MCNEIL PHARM INC·Filed 2001·Granted Mar 23, 2004·25 cites·71 claims
- 1483US6924302B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 2, 2005·21 cites·12 claims
- 1575US8153791B2Substituted pyrimidinyl oxime kinase inhibitorsXU GUOZHANG·Filed 2006·Granted Apr 10, 2012·5 cites·24 claims
- 1675US7888380B21,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 15, 2011·2 cites·27 claims
- 1774US11597746B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2019·Granted Mar 7, 2023·1 cites·53 claims
- 1873US2023287034A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1972US7205298B2Substituted triazine kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Apr 17, 2007·6 cites·10 claims
- 2071US2021040181A1Targeted therapeutics based on engineered proteins that bind egfrBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2171US2023144627A1Cyclic Dinucleotides As Sting AgonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2269US7196110B2N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disordersJANSSEN PHAMACEUTICA N V·Filed 2003·Granted Mar 27, 2007·6 cites·37 claims
- 2367US2023146410A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2463US2022403397A1Nucleic acid constructs encoding kallikrein-2 fusion protein and vectors, preparations of cells, and methods of use thereofJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2560US7427625B2Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 23, 2008·0 cites·19 claims
- 2660US2008300264A1Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsCONNOLLY PETER J·Filed 2008·Application pending·0 cites
- 2759US11492367B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 2856US7795440B2N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disordersJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 14, 2010·0 cites·2 claims
- 2954US11472830B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2017·Granted Oct 18, 2022·0 cites·19 claims
- 3050US2021009630A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3147US8314234B2Bicyclic pyrimidine kinase inhibitorsCONNOLLY PETER J·Filed 2007·Granted Nov 20, 2012·0 cites·7 claims
- 3246US7109220B2Amino substituted pyridinyl methanone compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 19, 2006·0 cites·10 claims
- 3346US7070938B2Method to detect modulators of VEGF kinase domainORTHO MCNEIL PHARM INC·Filed 2001·Granted Jul 4, 2006·0 cites·2 claims
- 3446US2007161648A1Substituted dihydro-isoindolones useful in treating kinase disordersHUGHES TERRY V·Filed 2006·Application pending·0 cites
- 3545US8367825B2Substituted pyrimidinyl oxime kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Feb 5, 2013·0 cites·13 claims
- 3645US2008293785A1Substituted benzothiazole kinase inhibitorsCONNOLLY PETER J·Filed 2007·Application pending·0 cites
- 3743US11021511B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Jun 1, 2021·0 cites·14 claims
- 3843US8299082B21,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivativesHUANG SHENLIN·Filed 2010·Granted Oct 30, 2012·0 cites·2 claims
- 3943US2008108611A1Substituted thienopyrimidine kinase inhibitorsBATTISTA KATHLEEN A·Filed 2007·Application pending·0 cites
- 4040US6287853B1Accessory factory function for interferon gamma and its receptorUNIV NEW JERSEY MED·Filed 1997·Granted Sep 11, 2001·6 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Stuart Emanuel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →